ONYX-411, a conditionally replicative oncolytic adenovirus, induces cell death in anaplastic thyroid carcinoma cell lines and suppresses the growth of xenograft tumors in nude mice-Reference-Cited by-同舟云学术

ONYX-411, a conditionally replicative oncolytic adenovirus, induces cell death in anaplastic thyroid carcinoma cell lines and suppresses the growth of xenograft tumors in nude mice

Published:2008-06-27 Issue:11 Volume:15 Page:750-757
ISSN:0929-1903
Container-title:Cancer Gene Therapy
language:en
Short-container-title:Cancer Gene Ther

Author:

Reddi H V,Madde P,Reichert-Eberhardt A J,Galanis E C,Copland J A,McIver B,Grebe S K G,Eberhardt N L

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/cgt200844.pdf

Reference27 articles.

1. http://www.cancer.org/docroot/stt/stt_0.asp .

2. Are C, Shaha AR . Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches. Ann Surg Oncol 2006; 13: 453–464.

3. Haigh PI . Anaplastic thyroid carcinoma. Curr Treat Options Oncol 2000; 1: 353–357.

4. Copland JA, Marlow LA, Kurakata S, Fujiwara K, Wong AK, Kreinest PA et al. Novel high-affinity PPARgamma agonist alone and in combination with paclitaxel inhibits human anaplastic thyroid carcinoma tumor growth via p21WAF1/CIP1. Oncogene 2006; 25: 2304–2317.

5. Elisei R, Vivaldi A, Ciampi R, Faviana P, Basolo F, Santini F et al. Treatment with drugs able to reduce iodine efflux significantly increases the intracellular retention time in thyroid cancer cells stably transfected with sodium iodide symporter complementary deoxyribonucleic acid. J Clin Endocrinol Metab 2006; 91: 2389–2395.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Viral therapy for targeted drug delivery to cancers: Recent advances, clinical and regulatory perspectives;Journal of Drug Delivery Science and Technology;2024-02

2. New Insights into Immune Cells and Immunotherapy for Thyroid Cancer;Immunological Investigations;2023-10-17

3. Virotherapy as a Potential Therapeutic Approach for the Treatment of Aggressive Thyroid Cancer;Cancers;2019-10-10

4. Oncolytic virotherapy for anaplastic and poorly differentiated thyroid cancer: a promise or a clinical reality?;International Journal of Endocrine Oncology;2018-11

5. Recombinant oncolytic Newcastle disease virus displays antitumor activities in anaplastic thyroid cancer cells;BMC Cancer;2018-07-18